Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24 2024 - 5:00PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
in life science research and clinical diagnostics products, will
report its financial results for the fourth quarter and full year
2023 on Thursday, February 15, 2024, following the close of the
market. Management will discuss these results in a conference call
scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
To participate, dial 888-259-6580 within the U.S. or +1
416-764-8624 outside the U.S., access code: 36826276. A live
webcast of the conference call will also be available in the
"Investor Relations" section of the company’s website under "Events
& Presentations" at investors.bio-rad.com. A replay of the
webcast will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
over 8,200 employees and $2.8 billion in revenues in 2022. Our
customers include universities, research institutions, hospitals,
food safety and environmental quality laboratories, and
biopharmaceutical companies. Together, we develop innovative,
high-quality products that advance science and save lives. To learn
more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240124239371/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 pr@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Apr 2024 to May 2024
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From May 2023 to May 2024